Results 31 to 40 of about 225,158 (305)

Could the mood disorder symptoms can be predict by metabolic disturbances?

European Psychiatry, 2022
Introduction Despite the huge progression in depression treatment, many individuals do not achieve full recovery. Studies demonstrated alternatives from neurotransmitter targets which are promising to predict and manage illness.
J. Rog, M. Futyma-Jędrzejewska, D. Juchnowicz, R. Karpiński, H. Karakula-Juchnowicz   +4 more
doaj   +1 more source

A Mitochondrial Health Index Sensitive to Mood and Caregiving Stress. [PDF]

, 2018
BACKGROUND:Chronic life stress, such as the stress of caregiving, can promote pathophysiology, but the underlying cellular mechanisms are not well understood.
Aschbacher, Kirstin, Burelle, Yan, Coccia, Michael, Cuillerier, Alexanne, Epel, Elissa S, Picard, Martin, Prather, Aric A, Puterman, Eli   +7 more
core   +1 more source

From theory to practice: challenges and rewards of implementing ketogenic metabolic therapy in mental health

Frontiers in Nutrition
This perspective article delves into the implementation of Ketogenic Metabolic Therapy (KMT) by a mental health counselor who attempts to bridge the gap between emerging research and real-world clinical application.
Nicole Laurent
doaj   +1 more source

Maternal caregivers have confluence of altered cortisol, high reward-driven eating, and worse metabolic health. [PDF]

, 2019
Animal models have shown that chronic stress increases cortisol, which contributes to overeating of highly palatable food, increased abdominal fat and lower cortisol reactivity. Few studies in humans have simultaneously examined these trajectories.
Epel, Elissa S, Laudenslager, Mark L, Mason, Ashley E, Radin, Rachel M   +3 more
core   +2 more sources

Ketogenic metabolic therapy in the remission of chronic major depressive disorder: a retrospective case study

Frontiers in Nutrition
BackgroundThere is limited evidence describing the use of ketogenic metabolic therapy (KMT), also known as a ketogenic diet (KD), to achieve full remission of treatment-resistant major depressive disorder (MDD) in real-world clinical settings.
Nicole Laurent, Erin L. Bellamy, Donika Hristova, Ally Houston   +3 more
doaj   +1 more source

Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort

BMC Psychiatry, 2022
Study objectives Insomnia disorders as well as cardiometabolic disorders are highly prevalent in the psychiatric population compared to the general population.
Nermine Laaboub, Céline Dubath, Setareh Ranjbar, Guibet Sibailly, Claire Grosu, Marianna Piras, Didier Délessert, Hélène Richard-Lepouriel, Nicolas Ansermot, Severine Crettol, Frederik Vandenberghe, Carole Grandjean, Aurélie Delacrétaz, Franziska Gamma, Kerstin Jessica Plessen, Armin von Gunten, Philippe Conus, Chin B. Eap   +17 more
doaj   +1 more source

Brain GABA and Glutamate Concentrations Following Chronic Gabapentin Administration: A Convenience Sample Studied During Early Abstinence From Alcohol. [PDF]

, 2018
Gabapentin (GBP), a GABA analog that may also affect glutamate (Glu) production, can normalize GABA and Glu tone during early abstinence from alcohol, effectively treating withdrawal symptoms and facilitating recovery.
Durazzo, Timothy C, Meyerhoff, Dieter J, Murray, Donna E, Pennington, David L   +3 more
core   +2 more sources

Case series: Effects of a ketogenic diet on cardiometabolic health in seven outpatients with bipolar disorder

Frontiers in Nutrition
BackgroundRecent research suggests that the ketogenic diet (KD) has the potential to serve as an effective treatment option for neuropsychiatric disorders, targeting both dysfunctions in brain metabolism and cardiometabolic comorbidities.
Louis Schreel, Maxi Bürkle, Andrea Thiem, Volker von Baehr, Joshua Sauren, Gerrit Keferstein   +5 more
doaj   +1 more source

Association between cognitive performance and cortical glucose metabolism in patients with mild Alzheimer's disease [PDF]

, 2005
Background: Neuronal and synaptic function in Alzheimer's disease (AD) is measured in vivo by glucose metabolism using positron emission tomography (PET). Objective: We hypothesized that neuronal activation as measured by PET is a more sensitive index of
A. Drzezga, A.L.W. Bokde, Baron JC, C. Born, Collins DL, G. Leinsinger, H. Hampel, H.-J. Moeller, Herholz K, Herscovitch P, Ibanez V, Ishii K, J. Thissen, Jueptner M, M. Schwaiger, McKhann G, Meltzer CC, Meltzer CC, Mentis MJ, Mentis MJ, P. Bartenstein, Pietrini P, Pietrini P, Pietrini P, Rapoport SI, S.J. Teipel, Sokoloff L, W. Dong   +27 more
core   +1 more source

Challenges and Frontiers in Computational Metabolic Psychiatry

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
One of the primary challenges in metabolic psychiatry is that the disrupted brain functions that underlie psychiatric conditions arise from a complex set of downstream and feedback processes spanning across multiple spatiotemporal scales. Importantly, the same circuit can have multiple points of failure, each of which results in a different type of ...
Anthony Chesebro, Botond Antal, Corey Weistuch, Lilianne Mujica-Parodi   +3 more
openaire   +2 more sources